88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

Phase II Trial of Cadonilimab(PD-1/CTLA-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer HONG KONG , July 14, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that it has entered into a collaboration with Memorial Sloan Kettering Cancer ... 2026-07-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Converging at BIO, ACROBiosystems Connects Emerging Innovation Assets with Global Strategic Opportunities SAN DIEGO , July 14, 2026 /PRNewswire/ -- Ahead of the BIO International Convention, BIOSeedin Summer Innovation Partnering Summit was successfully held at Wyndham San Diego Bayside, California. Hosted ... 2026-07-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
HKEY-AI-NAM-Bridge™ 1.0: HKeyBio Connects AI, NAMs and In Vivo Evidence HKEY-AI-NAM-Bridge™ 1.0 connects AI predictions, new approach methodologies and in vivo evidence for more targeted preclinical study design ... 2026-07-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business Acquisition supports Servier's strategic ambition in rare neurology with sevasemten, a late-stage investigational treatment for Becker and Duchenne muscular dystrophies. ... 2026-07-13T Health Care/Hospital Medical/Pharmaceuticals
Delonix Bioworks Announces First Participant Dosed in Phase 1 Clinical Trial of Next-Generation MenB OMV Vaccine DX-104 in China SHANGHAI , July 13, 2026 /PRNewswire/ -- Delonix Bioworks, a clinical-stage biotechnology company pioneering genetically engineered bacterial vaccines, today announced that the first participant has ... 2026-07-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Leads Biolabs Announces Multiple Studies Selected for ESMO 2026, Highlighting the Growing Global Competitiveness of Its Core Pipeline NANJING, China , July 13, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that six of its latest research ... 2026-07-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Boostimmune Secures Japanese Patent for Sequence-Independent TCTP Antibody Technology Targeting MDSC Accumulation Japanese patent granted for technology that inhibits TCTP released from dead tumor cells using antibodies to suppress the accumulation of MDSCs in the tumor microenvironment Granted claims are not expressly ... 2026-07-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
KLN Signs MOU with Advantech and YDCare to Support Digital Transformation of Hong Kong's Healthcare System HONG KONG , July 13, 2026 /PRNewswire/ -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK) announced that its healthcare subsidiary, KLN Medical Limited ('KLN Medical'), has signed a tripartite ... 2026-07-13T Computer/Electronics Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2026 LIFESTYLE PROGRAM IMPROVES BRAIN HEALTH AMONG OLDER ADULTS AT RISK FOR DEMENTIA ACROSS LATIN AMERICA - LatAm-FINGERS Study Findings Confirm and Expand U.S. POINTER Trial Results - - Show Structured Dementia Risk Reduction Strategies Adaptable Across Cultures - ... 2026-07-13T Health Care/Hospital Medical/Pharmaceuticals
Antengene Announces Receipt of USD 60 Million Upfront Payment from UCB SHANGHAI and HONG KONG , July 13, 2026 /PRNewswire/ -- Antengene Corporation Limited (" Antengene ", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated ... 2026-07-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved